Tesamorelin 10mg/vial – Research Grade Lyophilized Peptide

Core Product Introduction

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog formulated as a high-purity lyophilized powder for research and clinical exploration. This peptide is carefully designed to mimic the regulatory pathways of natural human growth hormone, exhibiting targeted bioactivity, making it an important tool for metabolic research, anti-aging research, and the management of lipid distribution disorders.

Tesamorelin’s unique mechanism of action—selective activation of the growth hormone-releasing hormone (GHRH) receptor—delivers four proven benefits, making it valuable across multiple research fields:

✅ Targeting Growth Hormone (GH) Secretion

1. Activates pituitary GHRH receptors, stimulating endogenous GH release

2. Mimics the physiological pulsatile secretion pattern, minimizing receptor desensitization and tolerance

3. Supports sustained increases in insulin-like growth factor-1 (IGF-1) levels, a key mediator of GH anabolic metabolism

✅ Precisely Reduces Visceral Fat

1. Selectively reduces abdominal visceral fat without affecting lean muscle mass

2. Improves body composition by shifting fat distribution from visceral to subcutaneous areas

3. Validated for research in HIV-associated lipid metabolism disorder, a disease characterized by abnormal visceral fat accumulation

✅ Metabolic Health Optimization

1. Enhances insulin sensitivity and supports healthy glycemic regulation

2. Improves lipid profile by lowering triglycerides and LDL cholesterol

3. Reduces cardiovascular disease risk factors associated with visceral obesity

✅ Good Safety and Tolerability

1. High receptor specificity minimizes off-target effects

2. Well-tolerated in long-term study settings

3. Avoids common side effects of non-selective growth hormone regulators (e.g., joint pain, peripheral edema, muscle atrophy)

Therefore, we recommend the following regimen:

1. Reconstitution Guidelines

* Use 1 mL of antibacterial water; inject slowly along the vial wall to avoid foaming

* Gently rotate until completely dissolved—do not vortex or shake vigorously (to maintain peptide structure)

* Storage after reconstitution: Refrigerate at 2–8°C; for best results, use within 7 days.

2. Injection Parameters

Subcutaneous Injection (Stable Absorption, Preferred)

Optimal Injection Sites: Abdomen (periumbilical subcutaneous fat layer – most stable absorption); Thigh (anterolateral subcutaneous fat layer)

Fat Loss Studies: 2 mg/day; Metabolic Optimization Studies: 1 mg/day

Dosage Frequency: Once daily, 30-60 minutes before bedtime

3. Injection Technique

Needle Selection: 29-31G 0.5-inch insulin needle

Injection Angle: 45 degrees (avoid intramuscular injection)

Injection Speed: Slow injection (10-15 seconds per 0.1 ml)

Injection Site Rotation: Alternate injection sites to prevent local irritation

4. Dosage Timing Precautions:

1. Administer before bedtime to coincide with the peak secretion period of human growth hormone at night.

2. Maintain a regular daily dosing schedule to ensure stable blood peptide concentrations.

Storage and Transportation Guidelines:

Long-term storage: -20°C (Shelf life 24 months)

Short-term storage: 2-8°C (Shelf life 12 months)

Storage Conditions: Store in a dry environment (relative humidity ≤30%), protected from light (brown glass bottle or aluminum foil packaging, refrigerated (2–8°C): shelf life up to 7 days. Do not freeze or repeatedly thaw and reconstitute the solution (this will destroy peptide activity).

Transportation:

Temperature Control: Use dry ice (-78°C) for long-distance transportation; use ice packs for short-distance transportation (2–8°C).

Packaging: Shockproof, leak-proof medical vials with rubber stoppers.

Shipping Time: We ship within 48 hours of order confirmation to ensure activity.